Table 3.

Characteristics of molecular analysis reported by published therapeutic efficacy reports on artemisinin-based combination therapy from sub-Saharan Africa

	n	N	%
Study shows genotyping data*	6	232	3
Study cites the 2007 WHO genotyping methodology†	41	129	32
Study explicitly states how samples with multiple alleles were analyzed	97	232	42
Consistent with the WHO methodology	74	97	76
Inconsistent with the WHO methodology	14	97	14
Unclear	9	97	9
Study specifies how fragment lengths were measured‡
Capillary sequencing	9	232	4
Gel electrophoresis	49	232	21
Not specified	174	232	75
Study specifies whether all loci were analyzed or if sequential approach was used§
All loci systematically assayed	2	201	1
Sequential	23	201	11
Not specified	176	201	88

N = number of articles assessed; n = number of articles with a finding.

^*Does not include two additional studies with example, illustrative genotyping data.

^†Among articles conducted after 2009.

^‡Among studies using fragment length polymorphic sites.

^§Among studies analyzing more than one locus.